Article Type
Changed
Fri, 01/04/2019 - 12:33
Display Headline
VIDEO: Immunotherapy as treatment for cervical cancer

CHICAGO – Research demonstrating that immunotherapy can be harnessed to treat metastatic cervical cancer was one of the highlights of the annual meeting of the American Society of Clinical Oncology.

We spoke with gynecologic cancer expert Dr. Don Dizon to learn more about why human papillomavirus-targeted T-cell therapy could work in cervical cancer and if this same cellular-based approach could be used in other virally mediated tumors.

Dr. Dizon is director of the Oncology Sexual Health Clinic at Massachusetts General Hospital Cancer Center in Boston.

He reported having no financial disclosures.

pwendling@frontlinemedcom.com

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
Meeting/Event
Author and Disclosure Information

Publications
Topics
Legacy Keywords
immunotherapy, metastatic cervical cancer, American Society of Clinical Oncology, gynecologic cancer, Dr. Don Dizon, human papillomavirus, T-cell therapy, cervical cancer,
Author and Disclosure Information

Author and Disclosure Information

Meeting/Event
Meeting/Event
Related Articles

CHICAGO – Research demonstrating that immunotherapy can be harnessed to treat metastatic cervical cancer was one of the highlights of the annual meeting of the American Society of Clinical Oncology.

We spoke with gynecologic cancer expert Dr. Don Dizon to learn more about why human papillomavirus-targeted T-cell therapy could work in cervical cancer and if this same cellular-based approach could be used in other virally mediated tumors.

Dr. Dizon is director of the Oncology Sexual Health Clinic at Massachusetts General Hospital Cancer Center in Boston.

He reported having no financial disclosures.

pwendling@frontlinemedcom.com

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

CHICAGO – Research demonstrating that immunotherapy can be harnessed to treat metastatic cervical cancer was one of the highlights of the annual meeting of the American Society of Clinical Oncology.

We spoke with gynecologic cancer expert Dr. Don Dizon to learn more about why human papillomavirus-targeted T-cell therapy could work in cervical cancer and if this same cellular-based approach could be used in other virally mediated tumors.

Dr. Dizon is director of the Oncology Sexual Health Clinic at Massachusetts General Hospital Cancer Center in Boston.

He reported having no financial disclosures.

pwendling@frontlinemedcom.com

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
Publications
Publications
Topics
Article Type
Display Headline
VIDEO: Immunotherapy as treatment for cervical cancer
Display Headline
VIDEO: Immunotherapy as treatment for cervical cancer
Legacy Keywords
immunotherapy, metastatic cervical cancer, American Society of Clinical Oncology, gynecologic cancer, Dr. Don Dizon, human papillomavirus, T-cell therapy, cervical cancer,
Legacy Keywords
immunotherapy, metastatic cervical cancer, American Society of Clinical Oncology, gynecologic cancer, Dr. Don Dizon, human papillomavirus, T-cell therapy, cervical cancer,
Article Source

AT ASCO ANNUAL MEETING 2014

PURLs Copyright

Inside the Article